Filing
Spy
Filing
Spy
Home
About
MRNS
Marinus Pharmaceuticals Inc
Biopharmaceutical company focused on seizure disorder therapeutics
CUSIP: 56854Q200
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2021 Q2
1 of 2 quarters
Total Value
$11.21M
Total Shares
625.0K
Net Share Change
+327.7K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Scion Asset Management
$11.21M
625.0K
0.5%
ADD
+327.7K
(+110.2%)
Scion Asset Management
$11.21M
625.0K shares
ADD
+327.7K
(+110.2%)
MRNS — Marinus Pharmaceuticals Inc - FilingSpy